06.10.2015 • News

Merged Dow-Olin Names New Executives

Dow Chemical and Olin Corporation completed their chlor-alkali, chlorinated organics and epoxy asset merger at the beginning of the third quarter and have appointed new executives to the combined company that will operate under the Olin umbrella.

The two new directors, designated by Dow in connection with the Reverse Morris Trust transaction, are William H. Weideman and Carol A. Williams.

During his 38 years at Dow, Weideman, 61, served in senior financial and management roles across Dow's portfolio of businesses and in his last position was chief financial officer and executive vice president from March 2010 to January 2015. He is also on the board of directors of Sadara Chemical Company, the joint venture with SABIC.

Williams, 57, served as a special advisor to the Dow CEO Andrew Liveris until early 2015. Prior to this, she was the chemical giant’s executive vice president of manufacturing and engineering, supply chain and environmental, health & safety operations. In an earlier position she was vice president for the North American chlor-alkali business.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.